HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.

AbstractOBJECTIVES:
We have previously described immune restoration diseases (IRD) associated with asymptomatic opportunistic infections presenting in immunodeficient HIV patients responding to highly active antiretroviral therapy (HAART). Here we address the question of whether patients with a history of IRD exhibit persistent immune activation, shown by elevated levels of interleukin-(IL)-6 and soluble IL-6 receptor (sIL-6R).
METHODS:
Peripheral blood mononuclear cells (PBMCs) and plasma were collected from HIV patients with nadir CD4 T cell counts of < 80/microL and who had achieved immune reconstitution after HAART with (n=14) or without (n=15) experiencing IRD, severely immunodeficient (SID) patients with < 80 CD4 T cells/microL (n=8) and HIV seronegative controls (n=15). PBMC production and plasma levels of IL-6, sIL-6R and interferon (IFN)-gamma (PBMC only) were measured by enzyme linked immunosorbent assay (ELISA). Intracellular flow cytometry was used to determine the predominant cellular source of IL-6 in HIV patients and controls.
RESULTS:
Unstimulated PBMC from IRD patients produced significantly higher amounts of IL-6 and sIL-6R than non-IRD patients and HIV seronegative controls. The sIL-6R concentration was also significantly higher in supernatants from mitogen-stimulated PBMC from IRD patients compared to non-IRD patients. The production of IFN-gamma did not differ between IRD and non-IRD patients. IRD patients had significantly higher plasma levels of IL-6 compared to non-IRD patients, SID patients and controls. Monocytes were the predominant source of IL-6 in both HIV patients and controls.
CONCLUSIONS:
Patients with a history of IRD after HAART have elevated levels of IL-6 and sIL-6R.
AuthorsS F Stone, P Price, N M Keane, R J Murray, M A French
JournalHIV medicine (HIV Med) Vol. 3 Issue 1 Pg. 21-7 (Jan 2002) ISSN: 1464-2662 [Print] England
PMID12059947 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • RNA, Viral
  • Receptors, Interleukin-6
  • Interferon-gamma
Topics
  • Adult
  • Antiretroviral Therapy, Highly Active (adverse effects)
  • CD4-Positive T-Lymphocytes (immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Flow Cytometry
  • HIV (immunology)
  • HIV Infections (blood, drug therapy, immunology)
  • Humans
  • Interferon-gamma (blood, immunology)
  • Interleukin-6 (blood, immunology)
  • Male
  • Middle Aged
  • RNA, Viral (blood)
  • Receptors, Interleukin-6 (blood, immunology)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: